Exponent's Revenue Estimates Keep Dropping But Analysts Haven't Downgraded Yet

Exponent Inc (EXPO) reports fiscal Q2 2026 earnings after market close on July 30, 2026, with analysts expecting $0.55 per share on revenue of $150.5 million. The engineering and scientific consulting firm has beaten estimates in four consecutive quarters, but investors will be watching whether the company can sustain its recent momentum amid questions about demand visibility and margin sustainability. With the stock trading at $65.85 and analysts maintaining a bullish stance with an average price target of $81.67, this report will test whether EXPO's growth trajectory justifies its valuation.

Part 1: Earnings Preview

Exponent Inc provides engineering and scientific consulting services, specializing in failure analysis, accident reconstruction, and regulatory compliance across industries including automotive, aerospace, health sciences, and consumer products. The company's multidisciplinary approach and deep technical expertise have made it a go-to resource for complex problem-solving and litigation support.

EXPO is scheduled to report fiscal Q2 2026 earnings after market close on July 30, 2026. Analysts expect earnings of $0.55 per share on revenue of $150.5 million. The company most recently reported $0.59 per share for fiscal Q1 2026, beating estimates by 5.36%. Compared to the same quarter last year when EXPO earned $0.52 per share, the current estimate of $0.55 represents year-over-year growth of 5.77%.

Three key themes define this earnings story:

Sustained Beat Streak and Margin Performance: EXPO has exceeded earnings estimates in four consecutive quarters, with beats ranging from 4.26% to 10.00%. Investors will watch whether the company can extend this streak while maintaining the strong operating margins that have characterized recent quarters, particularly as revenue estimates have been revised downward by 0.75% over the past three months.

Revenue Growth Trajectory: With consensus revenue estimates calling for $150.5 million (up 13.27% quarter-over-quarter according to analyst projections), the focus will be on whether EXPO can sustain double-digit sequential growth. The next quarter's estimate of $153.39 million suggests continued momentum, but recent downward revisions to near-term estimates raise questions about demand visibility.

Full-Year Outlook and 2027 Acceleration: Analysts project fiscal 2026 EPS of $2.28 (up 10.14% year-over-year) and fiscal 2027 EPS of $2.58 (up 13.16%), indicating expectations for accelerating growth. Management's commentary on the pipeline, utilization rates, and guidance for the second half of fiscal 2026 will be critical to validating this optimistic trajectory.

Analyst commentary ahead of the release reflects cautious optimism. The consensus has been revised upward significantly, with the current quarter estimate rising from $0.52 to $0.55, while the full-year estimate jumped from $2.07 to $2.28. However, the recent 0.75% downward revision to revenue estimates over the past three months suggests some near-term caution about top-line momentum.

Part 2: Historical Earnings Performance

EXPO has demonstrated consistent execution, beating earnings estimates in each of the past four quarters. The company reported $0.52 versus $0.48 estimated (beat of 8.33%), $0.55 versus $0.50 estimated (beat of 10.00%), $0.49 versus $0.47 estimated (beat of 4.26%), and most recently $0.59 versus $0.56 estimated (beat of 5.36%).

The pattern shows EXPO reliably exceeding expectations, with beats ranging from 4.26% to 10.00%. The average beat over this four-quarter period is approximately 6.99%, indicating the company has developed a track record of conservative guidance or strong operational execution. The most recent quarter's 5.36% beat was slightly below the prior quarter's 10.00% outperformance, but still comfortably above estimates.

This consistent beat pattern suggests EXPO has good visibility into its business and manages expectations effectively. With the current quarter estimate of $0.55 representing 5.77% year-over-year growth from the $0.52 reported in the same quarter last year, investors will watch whether the company can deliver another beat while maintaining its growth trajectory.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

EXPO typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

Historical price action shows EXPO exhibits moderate volatility around earnings, with an average absolute Day 0 move of 1.26% and Day +1 move of 4.24%. The Day +1 range averages 9.03%, indicating significant intraday volatility as the market digests results.

The most notable recent move came after the February 2026 report, when the stock surged 12.65% on Day +1 with an intraday range of 13.64%, suggesting a particularly strong reaction to results or guidance. Conversely, the October 2024 report triggered an 8.88% decline on Day +1, demonstrating the stock can move sharply in either direction.

More recent reports have shown more contained reactions, with the April 2026 earnings producing only a 2.41% Day +1 decline despite a beat. This suggests the market may be focusing more on forward guidance and business trends than the headline beat/miss. Investors should prepare for potential volatility in the 4-9% range on the day following results.

Part 2.2: Options Market Expected Move

The options market is pricing in a 0.00% expected move for the August 21, 2026 expiration, which appears to be a data anomaly given the stock's historical earnings volatility. Based on the historical average Day +1 move of 4.24%, investors should anticipate meaningful post-earnings price action despite the lack of a calculated implied move in the options data.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on EXPO with an average rating of 4.20 (Buy) and a consensus price target of $81.67, implying 24.0% upside from the current price of $65.85. The rating breakdown shows 3 Strong Buys, 0 Moderate Buys, 2 Holds, 0 Moderate Sells, and 0 Strong Sells among the 5 analysts covering the stock.

The sentiment trend is unchanged over the past month, with the rating composition holding steady at 3 Strong Buys and 2 Holds. This stability suggests analysts are maintaining conviction in their bullish thesis despite recent market volatility. The price target range spans from a low of $75.00 to a high of $90.00, with even the most conservative target implying 13.9% upside.

However, the average price target has been revised downward by 5.71% over the past three months, from approximately $86.60 to the current $81.67. This modest reduction suggests some recalibration of expectations, possibly reflecting the broader market environment or near-term growth concerns. Despite this adjustment, the consensus remains firmly in buy territory, indicating analysts believe EXPO's fundamental story remains intact and the stock offers attractive risk-reward heading into earnings.

Part 4: Technical Picture

The Barchart Technical Opinion shows a 24% Sell signal, representing a significant improvement from the 56% Sell reading last week and the 80% Sell signal from a month ago. This dramatic shift suggests technical momentum has improved substantially in recent weeks, though the signal remains in bearish territory.

Timeframe Analysis:

• Short-term (Hold): Neutral signal indicates near-term momentum has stabilized after recent weakness
• Medium-term (50% Sell): Moderate sell signal suggests the intermediate-term trend remains under pressure
• Long-term (50% Sell): Moderate sell signal reflects continued weakness in the longer-term trend structure

Trend Characteristics: The trend is characterized as Weak and Weakening, indicating the stock remains in a fragile technical position despite recent improvement in the short-term signal.

The stock is currently trading at $65.85, positioned above its 5-day ($63.01), 10-day ($62.64), 20-day ($62.17), 50-day ($59.61), and 100-day ($62.56) moving averages, but below its 200-day moving average ($67.05). This configuration shows EXPO has built short-term momentum and reclaimed key near-term support levels, but remains below its long-term trend line.

The technical setup heading into earnings is cautiously constructive. While the stock has recovered from recent lows and now trades above all short- and intermediate-term moving averages, the failure to reclaim the 200-day moving average at $67.05 keeps the longer-term trend in question. The 50-day moving average at $59.61 now provides key support, while the 200-day at $67.05 represents immediate overhead resistance. The improving short-term signal and position above multiple moving averages suggest buyers have returned, but the weak overall trend strength means the stock remains vulnerable to disappointment. A strong earnings beat with positive guidance could provide the catalyst to break above the 200-day moving average and establish a more durable uptrend, while any miss or cautious outlook could quickly reverse recent gains.